Chemoprevention of Cancer
Open accessThe DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Abstract
Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. The success of several recent clinical trials in preventing cancer in high-risk populations suggests that chemoprevention is a rational and appealing strategy. This review will highlight current clinical research in chemoprevention, the biologic effects of chemopreventive agents on epithelial carcinogenesis, and the usefulness of intermediate biomarkers as markers of premalignancy. Selected chemoprevention trials are discussed with a focus on strategies of trial design and clinical outcome. Future directions in the field of chemoprevention will be proposed that are based on recently acquired mechanistic insight into carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–250 of 250
A possible role for human papillomaviruses in head and neck cancer
Steinberg, B. M., & DiLorenzo, T. P. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00049489 · Cited by 98
Pathology, T. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)96325-p · Cited by 97
Wang, L., Soria, J., Kemp, B. L., Liu, D. D., Mao, L., & Khuri, F. R. (2002) · PubMed · Cited by 95
Low-Dose Isotretinoin Versus -Carotene to Prevent Oral Carcinogenesis: Long-term Follow-up
Papadimitrakopoulou, V. A., Hong, W. K., Lee, J. S., Lippman, S. M., Martin, J. W., Lee, J. J., & Batsakis, J. G. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.257 · Cited by 94
Self-citationPolek, T. C., & Weigel, N. L. (2002) · Journal of Andrology · doi:10.1002/j.1939-4640.2002.tb02596.x · Cited by 93
Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
Brambilla, E. M., Gazzéri, S., Moro‐Sibilot, D., Lantuéjoul, S., Veyrenc, S., & Brambilla, C. (1999) · PubMed · Cited by 93
Miyashiro, I., Senda, T., Matsumine, A., Baeg, G., Kuroda, T., Shimano, T., Miura, S., Noda, T., Kobayashi, S., & Monden, M. (1995) · PubMed · Cited by 88
Stern, R. S., Bolshakov, S. V., Nataraj, A. J., & Ananthaswamy, H. N. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01814.x · Cited by 88
Chemoprevention of Skin Cancer in Xeroderma Pigmentosum
Kraemer, K. H., DiGiovanna, J. J., & Peck, G. L. (1992) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1992.tb03766.x · Cited by 87
The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial
Arnold, A., Browman, G. P., Levine, M., D'Souza, T. J., Johnstone, B., Skingley, P., Turner-Smith, L. M., Cayco, R., Booker, L., Newhouse, M., et al. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.156 · Cited by 87
Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer.
Fukuse, T., Hirata, T., Naiki, H., Hitomï, S., & Wada, H. (2000) · PubMed · Cited by 86
Chemoprevention of lung cancer
Soria, J., Kim, E. S., Fayette, J., Lantuéjoul, S., Deutsch, É., & Hong, W. K. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01244-0 · Cited by 86
Self-citationLoss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer
Försti, A., Louhelainen, J., Söderberg, M. P., Wijkström, H., & Hemminki, K. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00118-6 · Cited by 83
Mitchell, M. F., Hittelman, W. N., Hong, W. K., Lotan, R., & Schottenfeld, D. (1994) · PubMed · Cited by 80
Self-citationChilders, J. M., Chu, J. Y., Voigt, L. F., et al. (1995) · PubMed · Cited by 79
Frankel, D. H., Hanusa, B. H., & Zitelli, J. A. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70100-t · Cited by 78
CHEMOPREVENTION OF UROLOGICAL CANCER
Kamat, A. M., & Lamm, D. L. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68793-9 · Cited by 75
de Vet, H. C. W., Knipschild, P. G., Willebrand, D., Schouten, H. J. A., & STURMANS, F. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90039-c · Cited by 74
Chu, T., Shen, C., Lee, H.-S., & Liu, H.-S. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199902)24:2<127::aid-gcc5>3.0.co;2-8 · Cited by 70
Ikegami, T., Matsuzaki, Y., Shoda, J., Kano, M., Hirabayashi, N., & Tanaka, N. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00248-1 · Cited by 69
Mackerras, D., Irwig, L., Simpson, J. M., Weisberg, E., Cardona, M., Webster, F., Walton, L., & Ghersi, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690231 · Cited by 68
Follen, M. M., Atkinson, E. N., Schottenfeld, D., Malpica, A. L., West, L. A., Lippman, S. M., Zou, C., Hittelman, W. N., Lotan, R., & Hong, W. K. (2001) · PubMed · Cited by 66
Self-citationSoria, J., Moon, C., Wang, L., Hittelman, W. N., Jang, S. J., Sun, S. Y., Lee, J. J., Liu, D., Kurie, J. M., Morice, R. C., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.16.1257 · Cited by 64
Self-citationKeefe, K. A., Schell, M. J., Brewer, C., McHale, M., Brewster, W. B., Chapman, J. A., Rose, G. S., McMeeken, D. S., Lagerberg, W., Peng, Y. M., et al. (2001) · PubMed · Cited by 63
Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas
Walker, C. A., Robertson, L. J., Myskow, M. W., & Dixon, G. R. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.295 · Cited by 61
The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation
Rodrigues, C. M. P., Kren, B. T., Steer, C. J., & Setchell, K. D. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90750-5 · Cited by 60
From Adjuvant Therapy to Breast Cancer Prevention: BCPT and STAR
Dunn, B. K., & Ford, L. G. (2001) · The Breast Journal · doi:10.1046/j.1524-4741.2001.007003144.x · Cited by 60
Shin, D. M., Mao, L., Papadimitrakopoulou, V. M., Clayman, G. L., El‐Naggar, A. K., Shin, H. J. C., Lee, J. J., Lee, J. S., Gillenwater, A. M., Myers, J. N., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.1.69 · Cited by 56
Self-citationMishina, T., Dosaka‐Akita, H., Kinoshita, I., Hommura, F., Morikawa, T., Katoh, H., & Kawakami, Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690500 · Cited by 55
Prostate Cancer Prevention Trial (PCPT) Update
Coltman, C. A., Thompson, I. M., & Feigl, P. (1999) · European Urology · doi:10.1159/000019895 · Cited by 54
Epidemiology of breast cancer – selected highlights
Cuzick, J. M. (2003) · The Breast · doi:10.1016/s0960-9776(03)00144-9 · Cited by 54
Powles, T. J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-60 · Cited by 54
Lippman, S. M., & Hong, W. K. (2002) · PubMed · Cited by 53
Self-citationRosenthal, A. N., Ryan, A., Hopster, D. J., & Jacobs, I. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10362 · Cited by 53
Alvarez, R. D., Conner, M., Weiss, H. L., Klug, P. M., Niwas, S., Manne, U., Bacus, J. V., Kagan, V., Sexton, K. C., Grubbs, C. J., et al. (2003) · PubMed · Cited by 53
Telomerase Activity in Human Benign Prostate Tissue and Prostatic Adenocarcinomas
Kallakury, B., Brien, T. P., Lowry, C. V., Muraca, P. J., Fisher, H. A. G., Kaufman, R. P., & Ross, J. S. (1997) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199708000-00003 · Cited by 47
Prevention of N‐Methylnitrosourea‐induced Colon Tumorigenesis by Ursodeoxycholic Acid in F344 Rats
Narisawa, T., Fukaura, Y., Terada, K., & Sekiguchi, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00489.x · Cited by 46
Performance of a semiautomated papanicolaou smear screening system
Sherman, M. E., SCHIFFMAN, M. H., Herrero, R., Kelly, D. P., Bratti, C., Mango, L. J., Alfaro, M., Hutchinson, M. L., Mena, F., Hildesheim, A., et al. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981025)84:5<273::aid-cncr2>3.0.co;2-# · Cited by 44
The scientific basis for regarding vitamin A and its analogues as anti-carcinogenic agents
Hicks, R. M. (1983) · Proceedings of The Nutrition Society · doi:10.1079/pns19830010 · Cited by 43
Seshadri, R., McLeay, W., Horsfall, D. J., & McCaul, K. A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960220)69:1<38::aid-ijc9>3.0.co;2-x · Cited by 36
Chemoprevention of lung cancer
Cohen, V., & Khuri, F. R. (2004) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000129754.97392.d5 · Cited by 34
893 Molecular damage in the bronchial epithelium of current and former smokers
Wistuba, I. I., Lam, S. C., Behrens, C., Virmani, A. K., Fong, K. M., LeRiche, J., Samet, J. M., Srivastava, S., Minna, J. D., & Gazdar, A. F. (1997) · Lung Cancer · doi:10.1016/s0169-5002(97)80271-1 · Cited by 28
Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
Vogel, V. G. (2001) · PubMed · Cited by 27
Molecular biology of lung cancer
Kaye, F. J. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00342-7 · Cited by 25
Cyclo-oxygenase and Colon Cancer: Clues to the Aspirin Effect?
Gustafson‐Svärd, C., Lilja, I., Hallböök, O. J., & Sjödahl, R. I. (1997) · Annals of Medicine · doi:10.3109/07853899708999342 · Cited by 20
Why phase II trials in cervical chemoprevention are negative: what have we learned?
Follen, M. M., Vlastos, A., Meyskens, F. L., et al. (2002) · Cancer Causes & Control · doi:10.1023/a:1020660527600 · Cited by 19
Chemoprevention of colorectal cancer
Clapper, M. L., Chang, W., & Meropol, N. J. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200107000-00015 · Cited by 19
Follen, M. M., Meyskens, F. L., Atkinson, E. N., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1293 · Cited by 17
Kim, S. H., Park, T. K., & Kwon, J. Y. (2003) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(03)00032-8 · Cited by 8
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Drug discovery from medicinal plants
Balunas, M. J., & Kinghorn, A. D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.012 · Cited by 1,810
Szliszka, E., Czuba, Z. P., Domino, M., Mazur, B., Zydowicz, G., & Król, W. (2009) · Molecules · doi:10.3390/molecules · Cited by 1,023
Anti-cancer potential of flavonoids: recent trends and future perspectives
Batra, P., & Sharma, A. K. (2013) · 3 Biotech · doi:10.1007/s13205-013-0117-5 · Cited by 550
Pinocembrin: A Novel Natural Compound with Versatile Pharmacological and Biological Activities
Rasul, A., Millimouno, F. M., Ali Eltayb, W., Ali, M., Li, J., & Li, X. (2013) · BioMed Research International · doi:10.1155/2013/379850 · Cited by 350
Ins and outs of dietary phytochemicals in cancer chemoprevention
Russo, G. L. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.02.014 · Cited by 337
Metadata
- Authors
- Tsao, A. S., Kim, E. S., & Hong, W. K.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2004-05-01
- Volume
- 54
- Issue
- 3
- Pages
- 150-180
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2000879602
- Cited by
- 331
- References
- 250
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.